Cargando…
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
Coronavirus disease 2019 (COVID-19) is a pandemic with no specific drugs and high fatality. The most urgent need is to find effective treatments. We sought to determine whether hydroxychloroquine (HCQ) application may reduce the death risk of critically ill COVID-19 patients. In this retrospective s...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Science China Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228868/ https://www.ncbi.nlm.nih.gov/pubmed/32418114 http://dx.doi.org/10.1007/s11427-020-1732-2 |